Marinus Pharmaceuticals Inc's Suppliers Performance

Name: Marinus Pharmaceuticals Inc 's (MRNS) Suppliers by Company, Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

MRNS's Supply Chain

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


MRNS Costs vs Sales of Suppliers Growth		Marinus Pharmaceuticals Inc recorded an increase in cost of sales by 56.92 % year on year, relative to one quarter ago cost of sales fell by -2.86 % in Q3. • More on MRNS Suppliers

Marinus Pharmaceuticals Inc recorded increase in cost of sales by 56.92 % year on year, compare to one quarter ago cost of sales fell by -2.86 % in Q3.

• More on MRNS Suppliers

Select the Relationship:

Suppliers ▼

Select the Category:

Comparison ▼

Suppliers ▼

Basic Report▼

Marinus Pharmaceuticals Inc's Comment on Supply Chain

The company conducts manufacturing through independent contract manufacturing organizations (CMOs) under individual purchase orders for clinical trials. It holds commercial supply agreements for ganaxolone API with its current manufacturer and supplier of finished bulk drug product. Additionally, the company has a master supply agreement with a second U.S.-based API supplier for process development and commercial supply of API and intermediates. The company has qualified and signed quality agreements with major CMOs and performs periodic quality audits. It anticipates that its existing suppliers can meet clinical trial and commercial supply requirements for ganaxolone and ZTALMY for at least the next three years. Orsini Pharmaceutical Services, LLC is a specialty pharmacy customer that dispenses ZTALMY directly to patients and accounts for approximately 99% of ZTALMY revenue to date.

Marinus Pharmaceuticals Inc's Comment on Supply Chain

MRNS's Stock Perfrormance relative to it's Suppliers

MRNS's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Marinus Pharmaceuticals Inc	31.48	31.47	-140.49	165
SUBTOTAL	0.00	0.00	0.00	-

Sources: Marinus Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on: Friday, September 18, 2026 2:07 PM
For your research, we’ve provided nine additional tables on Marinus Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.